CLINICAL TRIALS PROFILE FOR MECAMYLAMINE HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for mecamylamine hydrochloride
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00006399 ↗ | Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease | Completed | Alzheimer's Association | Phase 2 | 1999-09-01 | The goal of this study is to examine whether the administration of estrogen to post-menopausal women and women with mild to moderate Alzheimer's disease will enhance their memory and their capacity for learning. |
NCT00006399 ↗ | Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease | Completed | Eisai Inc. | Phase 2 | 1999-09-01 | The goal of this study is to examine whether the administration of estrogen to post-menopausal women and women with mild to moderate Alzheimer's disease will enhance their memory and their capacity for learning. |
NCT00006399 ↗ | Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease | Completed | Pfizer | Phase 2 | 1999-09-01 | The goal of this study is to examine whether the administration of estrogen to post-menopausal women and women with mild to moderate Alzheimer's disease will enhance their memory and their capacity for learning. |
NCT00006399 ↗ | Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease | Completed | National Center for Research Resources (NCRR) | Phase 2 | 1999-09-01 | The goal of this study is to examine whether the administration of estrogen to post-menopausal women and women with mild to moderate Alzheimer's disease will enhance their memory and their capacity for learning. |
NCT00018161 ↗ | Treatment to Quit Smoking | Completed | US Department of Veterans Affairs | Phase 2 | 1997-01-01 | This protocol evaluates the efficacy of combining pharmacologic treatments for smoking cessation, entailing the use of the nicotine skin patch with the nicotinic antagonist mecamylamine, with a specific behavioral therapy designed to inhibit the smoking urge. |
NCT00018161 ↗ | Treatment to Quit Smoking | Completed | VA Office of Research and Development | Phase 2 | 1997-01-01 | This protocol evaluates the efficacy of combining pharmacologic treatments for smoking cessation, entailing the use of the nicotine skin patch with the nicotinic antagonist mecamylamine, with a specific behavioral therapy designed to inhibit the smoking urge. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for mecamylamine hydrochloride
Condition Name
Clinical Trial Locations for mecamylamine hydrochloride
Trials by Country
Clinical Trial Progress for mecamylamine hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for mecamylamine hydrochloride
Sponsor Name